C. Ola Landgren, Leader, Translational & Clinical Oncology Program/Experimental Therapeutics at Sylvester Comprehensive Cancer Center, shared on LinkedIn:
“At Sylvester Myeloma Institute, University of Miami, Sylvester Comprehensive Cancer Center, we don’t just imagine a multiple myeloma cure, we are building the path to it. Driven by Innovation, Excellence, and Colloboration, our globally recognized scientists and clinicians are advancing the transformative therapies of tomorrow.
From pioneering lab-based discovery science, computational oncology, and clinical trials, to training the next generation of myeloma leaders through our Advanced Clinical Fellowship, Computational Fellowship, and International Scholars Program, Sylvester Myeloma Institute is where myeloma talent thrives and drives impact to improve patients’ lives.
Sylvester Myeloma Institute is one of the fastest growing myeloma programs at this time. We are a global leader in drug development, and we provide cutting-edge clinical care. We collaborate with other leading groups and innovative companies in the field. We are working together to move the field faster forward.
Come join us in beautiful Miami, we are always looking for talent!”
More insights from C. Ola Landgren.